��������

Eduardo Esquenazi, PhD, is the Founder and CEO of Sirenas LLC. He served as its founding CEO from 2012-2017 before resuming the role in late 2019. Whether he’s off the shores of Hawaii or in the boardroom of Sirenas’ San Diego headquarters, Dr. Esquenazi exudes passion for innovation in healthcare, with a focus on the development of disruptive technologies in the early drug discovery process. He oversees the company’s strategic growth and directs the discovery and informatics arms of the company, including library creation, acquisition of biodiversity and cutting edge data analytics. Dr. Esquenazi earned his doctorate in biology from the Center for Marine Biotechnology and Biomedicine at The Scripps Institution of Oceanography and The Skaggs School of Pharmacy at University of California, San Diego, and received his bachelor of science in biology and neuroscience from Vanderbilt University. He has published extensively on novel approaches in metabolomics and on computational models of neurobiological systems. He is the 2010 recipient of The San Diego Fellowship and the 2008 recipient of the National Institutes of Health Training Grant in Marine Biotechnology. Dr. Esquenazi has been featured on Biotech Nation, is a speaker at leading conferences, including a keynote address at The Gordon Research Conference on Marine Natural Products in 2016, a dual panel alongside Fabien Cousteau, at the South by Southwest Conference, Health Track in 2017, presented the “The Secret Language of Life” at TEDxUCSD in 2017, the keynote address at Datawest 2017 and at the Xconomy event Big Data Meets Big Biology in 2018.